乙酰辅酶A代谢与肿瘤转移

doi:10.16689/j.cnki.cn11-9349/r.2019.03.021

摘要
图/表
参考文献
相关文章 (0)

全文: PDF (1087 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要转移是恶性肿瘤最重要的特征之一，也是肿瘤患者最主要的致死原因。肿瘤转移涉及肿瘤细胞自身、肿瘤与微环境间的相互作用等多方面调控因素。然而，肿瘤转移的具体调控机制还远未揭示清楚。代谢重编程是肿瘤的另一重要特征，在肿瘤发生、发展中发挥重要作用。乙酰辅酶A是细胞内关键的代谢中间物，在蛋白乙酰化和脂质合成代谢中起关键作用。已知肿瘤发生发展过程中乙酰辅酶A代谢发生了重编程，为肿瘤的快速生长提供了合成代谢原料。近年来，多项研究在不同类型的肿瘤中发现了乙酰辅酶A代谢与肿瘤转移表型存在密切关联，并进一步揭示了乙酰辅酶A代谢调控肿瘤转移的作用机制。本文将从以下三方面对乙酰辅酶A代谢调控及其在肿瘤转移中的作用及机制进行综述：（1）概述乙酰辅酶A的功能、主要代谢途径及关键代谢酶；（2）乙酰辅酶A代谢重编程通过调控肿瘤细胞上皮-间质转化、黏附迁移能力以及干性等机制影响肿瘤的侵袭转移；（3）乙酰辅酶A代谢重编程调控肿瘤转移研究展望。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	1
	2高超
	1
	2王胜浩
	1
	2朱文伟
	1
	2陈进宏
	1
	2鲁明
	1
	2
	3钦伦秀

关键词 ：乙酰辅酶A代谢, 肿瘤转移, 蛋白乙酰化, 上皮-间质转化, 脂质合成

Abstract：Metastasis is an important hallmark of cancer and accounts for the majority of cancer-associated death. Cancer metastasis is regulated by multi-factors such as cancer cell itself and interactions between cancer cells and microenvironment. However， metastasis remains the most poorly understood component in cancer pathogenesis. Metabolic reprogramming is another important feature of cancer. Acetyl-CoA is a central metabolic intermediate， and plays a vital role in protein acetylation and lipid synthesis. Previous studies have shown that Acetyl-CoA metabolic alternation occurs in cancer progression， providing anabolic materials for the rapid proliferation of cancer cells. In recent years， several studies have reported close correlations between Acetyl-CoA metabolism alterations and tumor metastasis in several types of cancers， and have revealed the mechanisms underlying how Acetyl-CoA metabolic alterations promote cancer metastasis. This review will summarize recent progresses on the role Acetyl-CoA metabolic alteration in cancer metastasis from the following aspects: (1) brief introduction of the main metabolic pathways， key metabolic enzymes， and physiological roles of Acetyl-CoA metabolism;(2)Acetyl-CoA metabolism alterations regulate cancer metastasis by inducing epithelial-mesenchymal transition， cell adhesion and migration， and stemness of cancer cells;(3)future directions for the researches on the roles of Acetyl-CoA metabolism reprogramming in cancer metastasis.

Key words： Acetyl-CoA metabolism Cancer metastasis Protein acetylation Epithelial-mesenchymal transition Lipid synthesis

基金资助:国家自然科学基金（81502501，81472677，81672820）；国家科技重大专项（2017ZX10203207）

通讯作者: 钦伦秀，电子邮箱：qinlx@fudan.edu.cn；鲁明，电子邮箱：luming@huashan.org.cn

引用本文:

1，2高超，1，2王胜浩，1，2朱文伟，1，2陈进宏，1，2鲁明，1，2，3钦伦秀. 乙酰辅酶A代谢与肿瘤转移[J]. 肿瘤代谢与营养电子杂志, 2019, 6(3): 376-381.
1，2GAO Chao， 1，2WANG Sheng-hao， 1，2ZHU Wen-wei， 1，2CHEN Jin-hong，1，2LU Ming， 1，2，3QIN Lun-xiu. Acetyl-CoA metabolism and cancer metastasis. Electron J Metab Nutr Cancer, 2019, 6(3): 376-381.

1.Hanahan D， Weinberg Robert A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
2.Lambert AW， Pattabiraman DR， Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670-691.
3.Kitamura T， Qian BZ， Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15(2):73-86.
4.Pavlova Natalya N， Thompson Craig B. The emerging hallmarks of cancer metabolism. Cell Metabolism. 2016;23(1):27-47.
5.Finley LWS， Zhang J， Ye J， et al. Snap shot: cancer metabolism pathways. Cell Metab. 2013;17(3):466-466.e462.
6.Vander Heiden MG， Cantley LC， Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029-1033.
7.Shi L， Tu BP. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol. 2015;33:125-131.
8.Menzies KJ， Zhang H， Katsyuba E， et al. Protein acetylation in metabolism -metabolites and cofactors. Nat Rev Endocrinol. 2016;12(1):43-60.
9.Sivanand S， Viney I， Wellen KE. Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation. Trends Biochem Sci. 2018;43(1):61-74.
10.Pietrocola F， Galluzzi L， Bravo-San Pedro JM， et al. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 2015;21(6):805-821.
11.Cai L， Sutter BM， Li B， et al. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell. 2011;42(4):426-437.
12.Wente SR， Rout MP. The nuclear pore complex and nuclear transport. Cold Spring Harb Perspect Biol. 2010;2(10):a000562.
13.Takahashi H， McCaffery JM， Irizarry RA， et al. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol Cell. 2006;23(2):207-217.
14.Wellen KE， Hatzivassiliou G， Sachdeva UM， et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324(5930):1076-1080.
15.Lee JV， Carrer A， Shah S， et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 2014;20(2):306-319.
16.Lee JV， Shah SA， Wellen KE. Obesity， cancer， and acetyl-CoA metabolism. Drug Discov Today Dis Mech. 2013;10(1-2):e55-e61.
17.Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667-685.
18.Fritz KS， Green MF， Petersen DR， et al. Ethanol metabolism modifies hepatic protein acylation in mice. PLoS One. 2013;8(9):e75868.
19.Boroughs LK， DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351-359.
20.Zaidi N， Swinnen JV， Smans K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res. 2012;72(15):3709-3714.
21.Schug ZT， Peck B， Jones DT， et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 2015;27(1):57-71.
22.Gao X， Lin S-H， Ren F， et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016;7:11960.
23.Yang C， Ko B， Hensley CT， et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell. 2014;56(3):414-424.
24.Hunkeler M， Hagmann A， Stuttfeld E， et al. Structural basis for regulation of human acetyl-CoA carboxylase. Nature. 2018;558(7710):470-474.
25.Kirkby B， Roman N， Kobe B， et al. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog Lipid Res. 2010;49(4):366-377.
26.Lin R， Tao R， Gao X， et al. Acetylation stabilizes ATP-Citrate lyase to promote lipid biosynthesis and tumor growth. Molecular Cell. 2013;51(4):506-518.
27.Lu M， Zhu WW， Wang X， et al. ACOT12-Dependent alteration of acetyl-CoA drives hepatocellular carcinoma metastasis by epigenetic induction of epithelial-mesenchymal transition. Cell Metab. 2019;29(4):886-900.e885.
28.Lamouille S， Xu J， Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178-196.
29.De Craene B， Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nature reviews Cancer. 2013;13(2):97-110.
30.Rios Garcia M， Steinbauer B， Srivastava K， et al. Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence. Cell Metab. 2017;26(6):842-855 e845.
31.Jiang L， Xiao L， Sugiura H， et al. Metabolic reprogramming during TGF beta1-induced epithelial-to-mesenchymal transition. Oncogene. 2015;34(30):3908-3916.
32.Comerford Sarah A， Huang Z， Du X， et al. Acetate dependence of tumors. Cell. 2014;159(7):1591-1602.
33.Mashimo T， Pichumani K， Vemireddy V， et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell. 2014;159(7):1603-1614.
34.Sun L， Kong Y， Cao M， et al. Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma. Cancer Sci. 2017;108(7):1338-1346.
35.Stacpoole PW. Therapeutic targeting of the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis in cancer. J Natl Cancer Inst. 2017;109(11).
36.Hitosugi T， Fan J， Chung TW， et al. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell. 2011;44(6):864-877.
37.Sutendra G， Kinnaird A， Dromparis P， et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell. 2014;158(1):84-97.
38.Liu H， Huang X， Ye T. MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer. Am J Transl Res. 2018;10(3):659-669.
39.Hatzivassiliou G， Zhao F， Bauer DE， et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8(4):311-321.
40.Migita T， Narita T， Nomura K， et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 2008;68(20):8547-8554.
41.Lee JV， Berry CT， Kim K， et al. Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca(2+)-NFAT signaling. Genes Dev. 2018;32(7-8):497-511.
42.Martinez-Reyes I， Chandel NS. Acetyl-CoA-directed gene transcription in cancer cells. Genes Dev. 2018;32(7-8):463-465.
43.Skelding KA， Rostas JA， Verrills NM. Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II. Cell Cycle. 2011;10(4):631-639.
44.McCoy F， Darbandi R， Lee HC， et al. Metabolic activation of CaMKII by coenzyme A. Mol Cell. 2013;52(3):325-339.
45.Yu G， Cheng CJ， Lin SC， et al. Organelle-derived acetyl-CoA promotes prostate cancer cell survival， migration， and metastasis via activation of calmodulin kinase II. Cancer Res. 2018;78(10):2490-2502.
46.Martinez-Outschoorn UE， Prisco M， Ertel A， et al. Ketones and lactate increase cancer cell “stemness”， driving recurrence， metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle. 2011;10(8):1271-1286.
47.Tsuchiya Y， Pham U， Hu W， et al. Changes in acetyl CoA levels during the early embryonic development of Xenopus laevis. PLoS One. 2014;9(5):e97693.
48.Moussaieff A， Rouleau M， Kitsberg D， et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 2015;21(3):392-402.
49.Budhu A， Roessler S， Zhao X， et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 2013;144(5):1066-1075.e1061.
50.Rhrig F， Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732-749.
51.Menard JA， Christianson HC， Kucharzewska P， et al. Metastasis stimulation by hypoxia and acidosis-induced extracellular lipid uptake is mediated by proteoglycan-dependent endocytosis. Cancer Res. 2016;76(16):4828-4840.
52.Corbet C， Pinto A， Martherus R， et al. Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation. Cell Metab. 2016;24(2):311-323.
53.Pascual G， Avgustinova A， Mejetta S， et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41-45.
54.Wong BW， Wang X， Zecchin A， et al. The role of fatty acid β-oxidation in lymphangiogenesis. Nature. 2016;542(7639):49-54.
55.Luo X， Cheng C， Tan Z， et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76. doi: 10.1186/s12943-017-0646-3.
56.Granchi C. ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism. Eur J Med Chem. 2018;157:1276-1291.
57.Pollak MN. Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov. 2012;2(9):778-790.